Academic

Basel map
#Academic #Biotech #Drug development #Drug discovery #Life sciences

How the right environment accelerates biotech innovation

Christof Klöpper, CEO of Basel Area Business and Innovation, discusses how ecoystems for biotech can advance innovation and how the Basel area is an example of an impressive concentration of talent.  A decade ago, the typical formula for biotech locations went something like this: emerge from an academic institution or… Read More

#Exclusive Content

RNA
#Academic #Drug discovery #Single-cell analysis #Single-cell RNA sequencing

AI biotech company gives free access to single-cell sequencing

A new programme is offering academic researchers free access to advanced single-cell RNA sequencing to accelerate discovery across cancer and autoimmunity.  Immunai’s new academic initiative to support human immunology research is called the Immunai Grand Collaboration Initiative for Single-Cell Immune Profiling.  Through the programme, academic… Read More

#News

Lungs
#Academic #Clinical trials #Fibrosis #Halo Biosciences #Hypertension #Lung disease #Stanford University

Study suggests new hope for pulmonary hypertension

Halo Biosciences has announced publication of results in Thorax from the Phase IIa SATURN study for patients with pulmonary hypertension and interstitial lung disease (PH-ILD). The study, conducted at Stanford University, evaluated 4-methylumbelliferone (4-MU) in patients with pulmonary hypertension, a highly progressive disease with significant unmet needs. The Phase IIa… Read More

#News

Stand Up for Science, US, March 2025
#Academic #Aix-Marseille Université #Europe #Institut Pasteur #Politics #United States #Vrije Universiteit Brussel

European universities offer scientific refuge to US researchers

Several prestigious European universities are opening their doors to American scientific researchers to provide refuge from what they call “attacks on scientific facts and against researchers”.  The Vrije Universiteit Brussel (VUB) is opening 12 postdoctoral positions for international researchers, which are open to American researchers… Read More

#News #Trending News

University of Birmingham
#Academic #Drug discovery #Funding #Investment #Start-ups #University of Birmingham

Birmingham, UK, Drug Discovery Hub created

The Birmingham Drug Discovery Hub (BDDH) has been set up to help University of Birmingham researchers to overcome the ‘valley of death’, where projects fail due to the funding gap between original research and commercial investment. The hub has attracted more than £4 ($4.9) million in… Read More

#News #Start-up Zone

Scientific papers
#Academic #Data management #Neuroscience #Stanford University

Stanford president quits following false data accusations

The president of Stanford University in the US has announced he will resign after the university found that scientific papers he had published contained manipulated research data. The scientific misconduct inquiry did not find neuroscientist Marc Tessier-Lavigne guilty of falsifying research personally, but said that papers… Read More

#News #Trending News

Cancer research lab
#Academic #Cancer #Cancer research #Cancer Research Horizons #Cancer Research UK #Collaboration #Oncology

Academic-industry collaboration extends cancer drug alliance 

Cancer Research UK’s innovation engine, Cancer Research Horizons, and Newcastle University, have agreed an extension of their strategic drug discovery alliance with Astex Pharmaceuticals.  The alliance will continue to focus on the discovery of potential new cancer drugs with associated biomarkers, with the aim of providing an… Read More

#Cancer Research #News

#Academic #AI / data analytics / healthtech / informatics #Analysis #Cellular & Molecular biology #Chemistry #Clinical trials #Drug development #Drug discovery #Narrated podcasts

The COVID-19 Race: how mouse models will help researchers cross the finish line

The emergence of SARS-CoV-2 virus and the disease it causes, COVID-19, have fuelled significant shifts in preclinical research across the globe. Amid the worldwide health emergency created by high infection rates, rapid transmission spread and relatively high mortality rates, researchers are under pressure to understand the disease’s pathogenesis, develop… Read More

#Podcasts

#Academic #AI / data analytics / healthtech / informatics #Animal models #Biomarkers #Business #Cell therapy #Cellular & Molecular biology #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Combinatorial chemistry #Drug development #Drug discovery #Drug repositioning #Gene therapy #Genetics / genomes #High Content Screening #High throughput screening #Immunology #Immunology / Virology & Vaccines #Lead discovery #Molecular medicine #PCR #RNA #Screening #Stem cells #System biology #Systems biology #Therapeutics #Translational #Translational chemistry

Race To COVID-19 cure – the Core Model for solving the pandemic crisis (Part 1 & 2)

By Ibis Sanchez-Serrano and Rathnam Chaguturu Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes this disease. This article examines the major initiatives being explored at the… Read More

#Covid-19 #Exclusive Content

#Academic #AI / data analytics / healthtech / informatics #Animal models #Assay development optimisation & technology #Automation / robotics #Biomarkers #Business #Cell / tissue culture #Cell culture #Cellular assays #Clinical specialities #Clinical trials #Drug development #Drug discovery #Drug targets #Enabling technologies #High Content Screening #High throughput screening #Imaging #Lead discovery #Pharmokinetics #Preclinical #RNA #Screening #Stem cells #System biology #Systems biology #Target validation #Therapeutics #Toxicology #Translational #Translational chemistry

The CELL CULTURE innovations increasing drug discovery success

The CELL CULTURE innovations increasing drug discovery success By Helen Stewart-Miller and Abby George Volume 21 Issue 3 – Summer 2020 ‘Fail early, fail fast’ has been a mantra in the pharmaceutical industry for several years and directly impacts the overall strategy of many drug discovery and development… Read More

#Exclusive Content

#Academic #Analysis #Biomarkers #Clinical trials #Drug development #Gene therapy #Genomics #High Content Screening #Therapeutics

The Personalized Medicine Coalition

The Personalized Medicine Coalition The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized medicine concepts and products for the benefit of patients. As part of its… Read More

#Archive

#Academic #Analysis #Assay development optimisation & technology #Cell culture #Cellular assays #Chemistry #Drug discovery #Drug targets #Genetics / genomes #High Content Screening #High throughput screening #Immunology #Lead discovery #Medicinal chemistry #PCR #Pharmacology #RNA #Screening #Stem cells #System biology

Guidelines & Recommendations For Analyzing and Interpreting GPCR Second Messenger Data

Guidelines & Recommendations For Analyzing and Interpreting GPCR Second Messenger Data Sponsored by CisBio The question of choosing which methods to use for analyte quantification (signal vs concentration determination, parameters, and format) continues to generate heated debates and divergent understanding. Today, there is still… Read More

#Archive

#Academic #Analysis #Animal models #Assay development optimisation & technology #Biomarkers #Business #Cellular assays #Drug development #Drug discovery #Drug targets #Flow Cytometry #High Content Screening #High throughput screening #Immunology #Lead discovery #Pharmacology #RNA #Screening #Stem cells #Therapeutics #Toxicology

Advanced Therapeutic Antibody Discovery with Multiplexed Screening

Advanced Therapeutic Antibody Discovery with Multiplexed Screening Sponsored by Sartorius Antibody-based therapeutics are the fastest growing and most successful therapeutic modality for treating diseases such as cancer, cardiovascular disease, autoimmune disorders and infectious disease. It is predicted that by the year 2020 there will be 70… Read More

#Archive

#Academic #Analysis #Assay development optimisation & technology #Business #Drug development #Drug discovery #Enabling technologies #High Content Screening #High throughput screening #Immunology #Lead discovery #Microfluidics #Pharmokinetics #Screening #Therapeutics

Carterra closes financing round for LSA platform

Carterra closes financing round for continued growth of the LSA platform for next generation antibody dscovery. Carterra has closed a $6M round of financing led by Ballast Point Ventures with participation from current investor, Telegraph Hill Partners. The additional funding will support the continued adoption… Read More

#News

#Academic #AI / data analytics / healthtech / informatics #Genetics / genomes #High Content Screening #Immunology / Virology & Vaccines #RNA

The most discussed and shared scientific research of 2019

Climate crisis, artificial intelligence, and vaccines top the list of 2019’s most discussed research. From the increasing use of artificial intelligence to the climate emergency facing us all, many of this year’s most polarizing issues feature in the Altmetric Top 100, released today. The… Read More

#News

#Academic #Analysis #Assay development optimisation & technology #Cellular assays #Drug development #Drug discovery #Lead discovery #Lead optimisation #Preclinical #RNA #Screening #Target validation #Toxicology

Arctoris Ltd Successfully Moves into its New Global Headquarters in Oxford, UK

State-of-the art facility is home to the company’s next-generation, fully automated platform for drug discovery. Arctoris Ltd, the developer of the world’s first fully automated drug discovery platform, today opened the doors to its new global headquarters and state-of-the-art research and development (R&D) facility in Oxford,… Read More

#News